Background: It is well-documented that stroke volume and gradient are indexed to classify patients with aortic stenosis into several phenotypes. The purpose of the present study was to estimate the impact of stroke volume and gradient on the clinical outcome of patients with AS who have undergone aortic valve replacement.
INTRODUCTION
Aortic stenosis (AS) is a serious health problem worldwide. The most crucial pathological determinant is a chronic pressure overload onto the left ventricule caused by the calcified, immobile aortic valve, leading to concentric hypertrophy and myocardial fibrosis. Severe AS has been defined as aortic valve area (AVA) < 1 cm 2 with a mean gradient >40 mmHg. It is common for a patient to meet 1 or 2 of these criteria. Recently, there has been an increasing number of studies regarding low flow/low gradient (LF/LG) [Dumesnil 2010; Minners 2010; Voisine 2006 ]. To further define the hemodynamic features of severe AS, a recent flow-gradient classification has been proposed, incorporating both mean gradient and stroke volume. Aortic valve replacement (AVR), either surgical or by a transcatheter approach, is the sole definitive treatment for aortic stenosis that results in immediate relief of mechanical obstruction. AVR can improve outcome of patients with AS; however, there is controversy about its effect on AS patients with LF/LG despite normal LVEF (PLG-SAS) [Adda 2012; Clavel 2012; Hachicha 2007; Jander 2011] .
Accordingly, the aim of the present investigation was to determine the difference in clinical characteristics of patients with severe AS and preserved EF and the effects of AVR according to stroke volume and aortic valve gradient.
MATERIALS AND METHODS
A total of 863 consecutive patients were retrospectively studied. They had severe aortic stenosis and underwent aortic valve replacement (AVR) from January 1, 2004 to December 31, 2010. Patients aged <18, AVA > 1 cm², LVEF <50%, moderate to severe regurgitation, infectious endocarditis, contemporaneous other valve disease, cardiac surgery history and valve prosthesis were excluded. After exclusion, 154 patients were eligible for study and underwent AVR. This study was approved by the Ethics Committee of Changhai Hospital, Shanghai, China.
Baseline clinical data and echocardiography data were obtained by medical records and databases. Baseline clinical data consisted of age, sex, height, weight, body surface area (BSA), basal metabolic rate (BMI), smoke, duration of disease, symptoms (dyspnea, syncope, pectoralgia), hypertension, diabetes, atrial fibrillation, lung function, creatinine, time of cardiopulmonary bypass (CPB), bicuspid aortic valve, contemporaneous CABG, and NYHA class. 154 patients (100%) underwent echocardiography assessment preoperatively while systolic arterial pressure (SAP) and diastolic arterial pressure (DAP) were detected. Echocardiography assessment was completed by a doctor in the echocardiography department of Changhai Hospital, China. Zva was calculated by the following formula: Zva = (SAP+MG)/SVI.
Statistical analysis was performed with SAS software, Version 9.1 (SAS Institute, Cary, NC, USA). All continuous variables were expressed as mean ± standard deviation and were compared according to the Student t test or Wilcoxon rank-sum test between two groups. Categorical variables were expressed as percentages and compared according to Pearson chi-square test. Comparisons of continuous variables among the four groups were performed with Kruskal-Wallis test. Logistic regression analysis was used to screen the risk factors of the mortality after AVR (SLE = 0.10, SLS = 0.15). The survival of patients from different groups was obtained by Kaplan-Meier estimates. Finally, the Cox proportional-hazards model was (3) SVi, mL·m -2 45 ± 9.8 49 ± 10.6(1) 27 ± 5.0(1)(2) 30 ± 3.6(1) (2)(3) CI, L·min -1 ·m -2 3.3 ± 0.8 3.5 ± 1.0 2.2 ± 0.5(1)(2) 2.3 ± 0.5 (1)(2) Compared to NF/HG group (1) P < .05 compared to NF/LG group (2) P < .05 compared to LF/HG group (3) P < .05.
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used to assess the effect of clinical and echocardiography variables on survival. A P value ≤ .05 was considered statistically significant. Table 1 . The rate of female and syncope were significantly higher in the LF/HG group compared to the NF/HG group (57.5% and 37.3%, P < .05; 10.0% and 5.0%; P < .05). Among the NF/HG group, LF/HG group, and NF/LG group, time of CPB (104 ± 21.6 min, 112 ± 46.0 min and 94 ± 31.1 min; P < .05) was shortest in the NF/LG group. Zva was significantly higher in the LF/
RESULTS

Patient characteristics are shown in
LG group compared to the NF/HG group and the NF/LG group (5.1 ± 0.8 mmHg·mL -1 ·m -2 , 4.4 ± 1.0 mmHg·mL -1 ·m -2 and 3.2 ± 0.7 mmHg·mL -1 ·m -2 ; P < .05). Zva remained highest in the LF/HG group (7.4 ± 0.2 mmHg·mL -1 ·m -2 ; P < .05) and lowest in the NF/LG group (P < .05). In the 4 groups, Svi was highest in the NF/LG group (49 ± 10.6 mL·m -2 ; P < .05), and lowest in the LF/HG group (27 ± 5.0 mL·m -2 ; P < .05). SVi was significantly lower in the LF/LG group than in the NF/ HG group (30 ± 3.6 mL·m -2 and 45 ± 9.8 mL·m -2 ; P < .05). CI was significantly lower in the LF/HG group and LF/LG group (3.3 ± 0.8 L·min -1 ·m -2 , 3.5 ± 1.0 L·min -1 ·m -2 and 2.2 ± 0.5 L·min -1 ·m -2 , 2.3 ± 0.5 L·min -1 ·m -2 ; P < .05) compared to the NF/HG group and NF/LG group.
For the 154 patients, the mean follow-up time was 59 ± 32 months. In the in-hospital mortality, NF/HG was 1.7% compared with NF/LG (0), LF/HG (15.0%), and LF/LG (12.0%). The overall survival rates for the 4 groups were NF/HG (72%), NF/LG (92%), LF/HG (55%), and LF/LG (84%) (Figure 1 ). The BAV group was characterized by high overall mortality (Figure 2) . The 5-year survival rate was lower in the BAV group than in the 3-leaflets group (78% and 93%; P < .05). The risk factors of in-hospital mortality and overall mortality are shown in Table 2 and Table 3 . In the study, atrial fibrillation, concomitant coronary artery bypass graft, cardiac index, and bicuspid aortic valve were the independent values for the in-hospital mortality; and cardiac index, valvulo-arterial impedance, time of cardiopulmonary bypass, atrial fibrillation, bicuspid aortic valve and concomitant coronary artery bypass graft were the independent factors for the overall survival.
DISCUSSION
Low flow/low gradient and normal LV function are found in 5-25% among patients with AS. There is controversy for outcome of patients with PLG-SAS. Lancellotti et al used B-type natriuretic peptide (BNP) to estimate the outcome of LF/LG AS; the results indicated that the LF/LG and LF/HG groups had higher BNP and lower cardiac event-free survival compared with NF/HG and NF/LG groups [Lancellotti 2012 ]. Maes et al indicated that the paradoxical LG severe AS was a less malignant form of AS compared with HG severe AS, and its spontaneous outcome was better [Maes 2014 ]. Interestingly, Jander et al concluded that patients with LG AS and normal LVEF had an outcome similar to the patients with moderate stenosis (AVA = 1.0-1.5 cm²; MG = 25-40 mmHg) [Jander 2011 ].
LV function is an important factor that influences outcome of patients with AS who undergo AVR. The incidence of syncope is high in the LF/LG group, which may be due to concentric hypertrophy of LV, smaller volume and low SV [Clavel 2015 ]. More calcific leaflets, and restricted leaflets activity may have contributed to worse prognosis in the LF/
LG group than in the NF/HG group [Nishimura 2014 ]. In this study, patients with LF/LG had small AVA and small LV cavities. This indicates that these entities may have concentric remodeling of LV, reduced cavity size, and impaired diastolic and systolic function, which were unrevealed by LVEF. The condition suggests that the LVEF could not reveal the real LV systolic function. High valvulo-arterial impedance is also present in patients with LF/LG. It is reasonable that the high LV afterload leads to the adjustment of LV geometry, eg reduced cavity, changes in myocardial thickness, and concentric remodeling that will influence incidence of cardiac events. Recent studies have found the incidence of LV dysfunction increased 4-fold when Zva > 5 mmHg/(mL·m²) [Eleid 2013; Hachicha 2009 ]. Coincidently, Zva is an independent risk factor of survival after AVR.
In the present study, bicuspid aortic valve (BAV) has a high prevalence of 55.2% in all 154 patients. This ascertainment is inconsistent with recent studies. BAVs usually exhibit normal function at birth and during early life, but they can be associated with significant aortic valve disease prior to adulthood [Mathieu 2015] . Later in life BAVs are associated with substantial morbidity [Michelena 2008 ]. In particular, BAVs are predisposed to progressive calcification, grossly identical to that occurring in tricuspid aortic valves. Calcific stenosis of a BAV is generally accelerated approximately a decade earlier than with surgery. Calcified BAVs often become clinically important in patients as young as 50 years old; hence, it is reasonable that cases in this study presented younger. Structural abnormalities of the aortic wall commonly accompany BAV, and this may potentiate both aortic dilatation and aortic dissection [Mathieu 2015 ]. In the present study, patients with BAV are associated with lower survival rates. It may be due to the high prevalence of reoperation of dilated ascending aorta after isolated AVR.
This study demonstrates that patients with LF/HG are predisposed to the highest mortality among 4 groups, and higher prevalence of BAV in patients with LF/HG compared with NF/LG. Meanwhile, as logistic regression analysis is used to estimate the predictors of mortality, BAV is an independent predictor of in-hospital and long-term death. The AVA in patients with LF/HG was remarkably smaller than other classification patterns, which suggests that the impact of BAV on aortic valve and gradient may be worse. The smaller AVA and higher gradient contribute to more myocardial thickening, greater concentric remodeling, and higher Zva. This explains the worse outcome of patients with LF/HG, LF/LG. This study has a number of limitations. As this is a retrospective study, the data of patients who did not receive AVR are unavailable, and this might impact the outcome evaluation of patients after AVR. The sample size of the study is small which may lead to bias.
Conclusion
The in-hospital outcome of LF/LG was worse than NF/ HG and NF/LG, but similar to LF/HG. For the overall outcome, LF/LG was better than NF/HG and LF/HG, but worse than NF/LG. Patients with BAV exhibit worse survival compared to with 3-leaflets aortic valve. SVi indicates stroke volume index; Zva, valvulo-arterial impedance; CPB, cardiopulmonary bypass; AF, atrial fibrillation; BAV, bicuspid aortic valve; CO-CABG, concomitant coronary artery bypass graft; HR, hazard ratio; CI, confidence interval.
